Ken Fisher Novavax Inc Transaction History

Fisher Asset Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$36.28 - $75.29 $5,115 - $10,615	-141 Reduced 1.92%	7,212 $371,000
Q1 2022 May 05, 2022	BUY	$69.73 - $142.9 $348 - $714	5 Added 0.07%	7,353 $542,000
Q4 2021 Feb 02, 2022	BUY	$134.56 - $217.97 $14,397 - $23,322	107 Added 1.48%	7,348 $1.05 Million
Q3 2021 Oct 26, 2021	BUY	$177.8 - $270.58 $7,645 - $11,634	43 Added 0.6%	7,241 $1.5 Million
Q2 2021 Jul 27, 2021	SELL	$121.0 - $257.67 $9,680 - $20,613	-80 Reduced 1.1%	7,198 $1.53 Million
Q1 2021 Apr 27, 2021	SELL	$112.98 - $319.93 $7,795 - $22,075	-69 Reduced 0.94%	7,278 $1.32 Million
Q4 2020 Jan 29, 2021	BUY	$78.74 - $139.5 $11,811 - $20,925	150 Added 2.08%	7,347 $819,000
Q2 2020 Aug 07, 2020	BUY	$13.86 - $83.61 $99,750 - $601,741	7,197 New	7,197 $600,000

288

94.7M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $689M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Fisher Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Fisher Asset Management, LLC and Ken Fisher with notifications on news.